This consulting service recognizes the impact of MDROs on patient safety, as well as the economic toll of healthcare-associated infections. More than 70 percent of the bacteria that cause infections for 2 million hospitalized Americans each year are resistant to at least one of the drugs most commonly used to treat them, according to the Centers for Disease Control and Prevention (CDC).
Joint Commission Resources consultants will assess an organizations risks and capacity to address MDRO prevention, and use evidence-based processes to implement sustainable changes. The goals of the service are to reduced MDRO infection rates, improve patient safety, lower operational costs and increase consumer confidence. The framework for JCRs MDRO consulting service is based on guidelines from leading organizations including the CDC, the Association for Professionals in Infection Control and Epidemiology (APIC), the Society for Healthcare Epidemiology of America (SHEA) and The Joint Commission.
Source: Joint Commission Resources